Login / Signup

A pooled analysis of serious infections and herpes zoster-related disease in Asian patients with rheumatoid arthritis treated with peficitinib (ASP015K) over a median of 3 years.

Yoshiya TanakaTsutomu TakeuchiDaisuke KatoYuichiro KanekoMusashi FukudaHiroyuki IzutsuMitsuhiro Rokuda
Published in: Modern rheumatology (2022)
As expected in this peficitinib-treated population, older patients had increased risk of SI and HZD, and those receiving higher prednisolone doses had increased risk of SI.
Keyphrases
  • room temperature
  • newly diagnosed